Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
PaperCitations, authors & open-access status
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 112 citations, 2024 year and hybrid oa status.
112
Citations
2024
Year
hybrid
OA Status